Results 91 to 100 of about 13,620 (172)

Diagnosis Molekuler Virus Flu Burung-A Subtipe H5 Berdasarkan Amplifikasi Gen M dan H5 dengan Metode Onestep Simplex RT-PCR (MOLECULAR DIAGNOSIS OF AVIAN INFLUENZA VIRUS TYPE A AND SUBTYPE H5 BY AMPLIFICATION OF ITS M AND H5 GENES USING ONE STEP SIMPLEX R

Jurnal Veteriner, 2014
Influenza A viruses which belong to the Family of Orthomyxoviridae are a group of viruses withsegmented ssRNA genome. The viruses can be subgroupped into many subtypes on the basis of theirsurface glycoproteins, hemagglutinin (HA) and neuraminidase (NA ...
Aris Haryanto, Bibiana Krisanti, Sri Handayani Irianingsih, Dini Wahyu Yudianingtyas   +3 more
doaj  

The role of stearate attachment to the hemagglutinin-esterase-fusion glycoprotein HEF of influenza C virus [PDF]

Cellular Microbiology, 2015
Mingyang Wang, Kai Ludwig, Christoph Böttcher, Michael Veit   +3 more
openaire   +1 more source

Administration of antigenically distinct influenza viral particle combinations as an influenza vaccine strategy.

PLoS Pathogens
One approach for developing a more universal influenza vaccine is to elicit strong immune responses against canonically immunosubdominant epitopes in the surface exposed viral glycoproteins.
Xinyu Zhu, Zhaochen Luo, Rebecca A Leonard, Cait E Hamele, Rachel L Spreng, Nicholas S Heaton   +5 more
doaj   +1 more source

Expanding Horizons: Host Range Evolution and Treatment Strategies for Highly Pathogenic Avian Influenza H5N1 and H7N9. [PDF]

Viruses
Gazik NH, Holodniy M, Bayat V.
europepmc   +1 more source

Comparative N‑glycoproteomics Characterization of N‑glycoproteins of H3N8 Viruses Produced in Chicken Embryos versus MDCK Cells. [PDF]

ACS Omega
Wang H, Zhang Z, Zhang X, Zhao L, Liu X, Ye Q, Tan WS.   +6 more
europepmc   +1 more source

AI-Powered Identification of Human Cell Surface Protein Interactors of the Hemagglutinin Glycoprotein of High-Pandemic-Risk H5N1 Influenza Virus. [PDF]

Viruses
Poitras C, Coulombe B.
europepmc   +1 more source

Anti-neuraminidase and anti-HA stalk antibodies reduce the susceptibility to and infectivity of influenza A/H3N2 virus. [PDF]

Nat Commun
Hoy G, Cortier T, Maier HE, Kuan G, Lopez R, Sanchez N, Ojeda S, Plazaola M, Stadlbauer D, Shotwell A, Balmaseda A, Krammer F, Cauchemez S, Gordon A.   +13 more
europepmc   +1 more source

A primary oseltamivir-resistant mutation in influenza hemagglutinin and its implications for antiviral resistance surveillance. [PDF]

Nat Commun
Zhang L, Shao Y, Zou X, Cui Y, Ding S, Chen Y, Wu Q, Mu S, Li X, Yang Q, Cao B, Deng T.   +11 more
europepmc   +1 more source

Influenza hemagglutinin and neuraminidase multivalent vaccine elicits broader protective immune responses compared to vaccine formulations composed of hemagglutinin or neuraminidase. [PDF]

Hum Vaccin Immunother
Uno N, Ross TM.
europepmc   +1 more source

Chronology of H3N2 human influenza virus surface glycoprotein adaptation from 1968 to 2019 reveals a surge of adaptation between 1997 and 2002. [PDF]

J Virol
Lei H, Xiao B, Lin X, Liang Z, Ling S, Bai Y, Dhanasekaran V, Song W, Wong S-S, Zanin M.   +9 more
europepmc   +1 more source